Annals of Diagnostic Pathology
Volume 16, Issue 1 , Pages 1-6 , January 2012

Association of mast cells with microvessel density in urothelial carcinomas of the urinary bladder

  • Aysegul Sari, MD

      Affiliations

    • Pathology Department, Izmir Ataturk Researh and Training Hospital, Izmır, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +905325265215.
    • ,
  • Aylin Calli, MD

      Affiliations

    • Pathology Department, Izmir Ataturk Researh and Training Hospital, Izmır, Turkey
    • ,
  • Fulya Cakalagaoglu, MD

      Affiliations

    • Pathology Department, Izmir Ataturk Researh and Training Hospital, Izmır, Turkey
    • ,
  • Aysegul Aksoy Altınboga, MD

      Affiliations

    • Pathology Department, Izmir Ataturk Researh and Training Hospital, Izmır, Turkey
    • ,
  • Kaan Bal, MD

      Affiliations

    • Department of 2nd Urology, Izmir Ataturk Researh and Training Hospital, Izmır, Turkey

References 

  1. Jones A, Fujiyama C. Angiogenesis in urological malignancy: prognostic indicator and therapeutic target. BJU Int. 1999;83(5):535–555
  2. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8
  3. Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143:401–409
  4. Macchiarini P, Fontanini G, Hardin MJ, et al. Relation of neovascularization to metastasis of non–small lung cancer. Lancet. 1992;340:145–146
  5. Sawatsubashi M, Yamada T, Fukushima N, et al. Association of vascular endothelial growth factor and MCs with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch. 2000;436(3):243–248
  6. Bochner BH, Cote RJ, Weidner N, et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst. 1995;87:1603–1612
  7. Dinney CP, Babkowski RC, Antelo M, et al. Relationship among cystectomy, microvessel density and prognosis in stage T1 urothelial carcinoma of the bladder. J Urol. 1998;160(4):1285–1290
  8. Sagol O, Yorukoglu K, Sis B, et al. Does angiogenesis predict recurrence in superficial urothelial carcinoma of the bladder?. Urology. 2001;57(5):895–899
  9. Santos L, Costa C, Pereira S, et al. Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours. Ann Oncol. 2003;14(9):1419–1424
  10. Canoğlu A, Göğüş C, Bedük Y, et al. Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis. Int Urol Nephrol. 2004;36(3):401–405
  11. Stavropoulos NE, Bouropoulos C, Ioachim IE, et al. Prognostic significance of angiogenesis in superficial bladder cancer. Int Urol Nephrol. 2004;36(2):163–167
  12. Carlini MJ, Dalurzo MC, Lastiri JM, et al. Mast cell phenotypes and microvessels in non–small cell lung cancer and its prognostic significance. Hum Pathol. 2010;41(5):697–705
  13. Huang B, Lei Z, Zhang GM, et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood. 2008;112(4):1269–1279
  14. Theoharides TC, Conti P. MCs: the Jekyll and Hyde of tumor growth. Trend Immunol. 2004;25(5):235–241Review
  15. Acikalin MF, Oner U, Topçu I, et al. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Dig Liver Dis. 2005;37(3):162–169Epub 2004 Dec 9
  16. Ribatti D, Guidolin D, Marzullo A, et al. MCs and angiogenesis in gastric carcinoma. Int J Exp Pathol. 2010;91(4):350–356Epub 2010 Apr 20
  17. Amini RM, Aaltonen K, Nevanlinna H, et al. MCs and eosinophils in invasive breast carcinoma. BMC Cancer. 2007;7:165
  18. Crivellato E, Nico B, Ribatti D. MCs and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett. 2008;269(1):1–6Epub 2008 May 2. Review
  19. Ribatti D, Crivellato E. Mast cells, angiogenesis and tumour growth. Biochim Biophys Acta. 2011;716:270–288
  20. Esposito I, Kleeff J, Bischoff SC, et al. The stem cell factor-c-Kit system and MCs in human pancreatic cancer. Lab Invest. 2002;82(11):1481–1492
  21. Hartveit F, Thoresen S, Tangen M, et al. Mast cell changes and tumour dissemination in human breast carcinoma. Invasion Metastasis. 1984;4(3):146–155
  22. Yano H, Kinuta M, Tateishi H, et al. Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer. 1999;2(1):26–32
  23. Iamaroon A, Pongsiriwet S, Jittidecharaks S, et al. Increase of MCs and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med. 2003;32(4):195–199
  24. Imada A, Shijubo N, Kojima H, et al. MCs correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J. 2000;15(6):1087–1093
  25. Gupta RK. Mast cell variations in prostate and urinary bladder. Arch Pathol. 1970;89(4):302–305
  26. Serel TA, Soyupek S, Candir O. Association between MCs and bladder carcinoma. Urol Int. 2004;72(4):299–302
  27. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. In:  Kleihues P,  Sobin LH editor. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC); 2004;p. 90–109
  28. Sobin LH, Wittekind C. Urological tumors. In:  Sobin LH,  Wittekind C editor. TNM Classification of Malignant Tumors. 6th ed. New York: Wiley; 2002;
  29. Campbell SC. Advances in angiogenesis research: relevance to urological oncology. J Urol. 1997;158(5):1663–1674
  30. Jaeger TM, Weidner N, Chew K, et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol. 1995;154(1):69–71
  31. Chaudhary R, Bromley M, Clarke NW, et al. Prognostic relevance of micro-vessel density in cancer of the urinary bladder. Anticancer Res. 1999;19(4C):3479–3484
  32. Goddard JC, Sutton CD, Berry DP, et al. The use of microvessel density in assessing human urological tumours. BJU Int. 2001;87(9):866–875
  33. Starkey JR, Crowle PK, Taubenberger S. Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis.. Int J Cancer. 1988;42(1):48–52
  34. Dabiri S, Huntsman D, Makretsov N, et al. The presence of stromal MCs identifies a subset of invasive breast cancers with a favorable prognosis. Mod Pathol. 2004;17(6):690–695
  35. Tan SY, Fan Y, Luo HS, et al. Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol. 2005;11(8):1210–1214
  36. Galli SJ. New insights into “the riddle of the MCs”: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest. 1990;62(1):5–33Review
  37. Wilk M, Liszka Ł, Paleń P, et al. Intensity of angiogenesis and mast cell infiltration in cervical intraepithelial and invasive lesions—are they correlated?. Pathol Res Pract. 2010;206(4):217–222
  38. Franceschini B, Ceva-Grimaldi G, Russo C, et al. Complex functions of MCs in chronic human liver diseases. Dig Dis Sci. 2006;51(12):2248–2256Review

PII: S1092-9134(11)00104-3

doi: 10.1016/j.anndiagpath.2011.07.001

Annals of Diagnostic Pathology
Volume 16, Issue 1 , Pages 1-6 , January 2012

Article Tools

* Image Usage & Resolution